Clorox Company (The) (CLX) Receives Coverage Optimism Rating of 0.17

News coverage about Clorox Company (The) (NYSE:CLX) has been trending somewhat positive this week, according to Accern Sentiment. The research firm identifies positive and negative press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Clorox Company (The) earned a media sentiment score of 0.17 on Accern’s scale. Accern also assigned media coverage about the company an impact score of 46.4342107606599 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Here are some of the news headlines that may have effected Accern Sentiment’s rankings:

A number of equities analysts have issued reports on CLX shares. Deutsche Bank AG reiterated a “hold” rating and set a $137.00 price target (up previously from $126.00) on shares of Clorox Company (The) in a research note on Saturday, July 22nd. BMO Capital Markets reiterated an “outperform” rating on shares of Clorox Company (The) in a research note on Tuesday, September 12th. BidaskClub downgraded Clorox Company (The) from a “hold” rating to a “sell” rating in a research note on Wednesday, July 5th. Zacks Investment Research upgraded Clorox Company (The) from a “hold” rating to a “buy” rating and set a $149.00 price target for the company in a research note on Tuesday, July 4th. Finally, Royal Bank Of Canada reiterated a “hold” rating and set a $115.00 price target on shares of Clorox Company (The) in a research note on Friday, June 30th. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $127.81.

Clorox Company (CLX) opened at 136.18 on Friday. The stock has a 50 day moving average price of $135.92 and a 200-day moving average price of $135.24. The stock has a market cap of $17.58 billion, a P/E ratio of 25.53 and a beta of 0.40. Clorox Company has a 52 week low of $111.24 and a 52 week high of $141.76.

Clorox Company (The) (NYSE:CLX) last announced its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.49 by $0.04. The company had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.65 billion. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The firm’s quarterly revenue was up 2.9% compared to the same quarter last year. During the same quarter last year, the firm earned $1.30 earnings per share. On average, equities analysts anticipate that Clorox Company will post $5.66 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Monday, November 13th. Investors of record on Wednesday, October 25th will be given a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a dividend yield of 2.47%. The ex-dividend date of this dividend is Tuesday, October 24th. Clorox Company (The)’s dividend payout ratio (DPR) is currently 63.04%.

In related news, SVP Jon M. Balousek sold 9,223 shares of the firm’s stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $138.87, for a total transaction of $1,280,798.01. Following the completion of the sale, the senior vice president now owns 20,614 shares of the company’s stock, valued at $2,862,666.18. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Dawn C. Willoughby sold 2,158 shares of the firm’s stock in a transaction that occurred on Tuesday, August 29th. The shares were sold at an average price of $138.00, for a total transaction of $297,804.00. The disclosure for this sale can be found here. Insiders have sold 21,242 shares of company stock valued at $2,944,449 in the last three months. 0.74% of the stock is owned by insiders.

ILLEGAL ACTIVITY WARNING: This article was first published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this article on another domain, it was stolen and reposted in violation of United States & international copyright and trademark law. The original version of this article can be read at

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Insider Buying and Selling by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with's FREE daily email newsletter.

Leave a Reply